HuaTeng Biotechnology provides a versatile preclinical platform for evaluating acute and chronic hepatitis, covering diverse etiologies including T-cell-mediated autoimmunity, acute cytokine storm, and chemical hepatotoxicity. By establishing tightly controlled in vivo models, we replicate clinical intrahepatic immune infiltration, parenchymal necrosis, and systemic inflammatory cascades.